Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 5, 2024

Accession no.
0001628280-24-045334
Filed
Nov 5, 2024
Trade date
Oct 1-31, 2024
Filing delay
35 daysLate
Rule 10b5-1 plan
Checked

This filing lists 23 non-derivative transactions and 0 derivative transactions. Open-market purchases total $913.57. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2024Common StockPPurchaseAcquired+31$1.27+$39.3728,335Direct
Oct 2, 2024Common StockPPurchaseAcquired+31$1.29+$39.9928,366Direct
Oct 3, 2024Common StockPPurchaseAcquired+31$1.28+$39.6828,397Direct
Oct 4, 2024Common StockPPurchaseAcquired+31$1.28+$39.6828,428Direct
Oct 7, 2024Common StockPPurchaseAcquired+31$1.29+$39.9928,459Direct
Oct 8, 2024Common StockPPurchaseAcquired+31$1.30+$40.328,490Direct
Oct 9, 2024Common StockPPurchaseAcquired+31$1.31+$40.6128,521Direct
Oct 10, 2024Common StockPPurchaseAcquired+31$1.32+$40.9228,552Direct
Oct 11, 2024Common StockPPurchaseAcquired+31$1.39+$43.0928,583Direct
Oct 14, 2024Common StockPPurchaseAcquired+31$1.37+$42.4728,614Direct
Oct 15, 2024Common StockPPurchaseAcquired+31$1.30+$40.328,645Direct
Oct 16, 2024Common StockPPurchaseAcquired+31$1.25+$38.7528,676Direct
Oct 17, 2024Common StockPPurchaseAcquired+31$1.30+$40.328,707Direct
Oct 18, 2024Common StockPPurchaseAcquired+31$1.28+$39.6828,738Direct
Oct 21, 2024Common StockPPurchaseAcquired+31$1.25+$38.7528,769Direct
Oct 22, 2024Common StockPPurchaseAcquired+31$1.25+$38.7528,800Direct
Oct 23, 2024Common StockPPurchaseAcquired+31$1.26+$39.0628,831Direct
Oct 24, 2024Common StockPPurchaseAcquired+31$1.24+$38.4428,862Direct
Oct 25, 2024Common StockPPurchaseAcquired+31$1.23+$38.1328,893Direct
Oct 28, 2024Common StockPPurchaseAcquired+31$1.25+$38.7528,924Direct
Oct 29, 2024Common StockPPurchaseAcquired+31$1.24+$38.4428,955Direct
Oct 30, 2024Common StockPPurchaseAcquired+31$1.32+$40.9228,986Direct
Oct 31, 2024Common StockPPurchaseAcquired+31$1.20+$37.229,017Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)